In a world first, scientists have found a new way to direct stem cells to heart tissue. The findings, led by researchers at the University of Bristol and published in Chemical Science, could radically improve the treatment for cardiovascular disease, which causes more than a quarter of all deaths in the UK.
To date, trials using stem cells, which are taken and grown from the patient or donor and injected into the patient’s heart to regenerate damaged tissue, have produced promising results.
However, while these next generation cell therapies are on the horizon, significant challenges associated with the distribution of the stem cells have remained. High blood flow in the heart combined with various ’tissue sinks’, that circulating cells come into contact with, means the majority of the stem cells end up in the lungs and spleen.
Now, researchers from Bristol’s School of Cellular and Molecular Medicine have found a way to overcome this by modifying stem cells with a special protein so they ‘home’ to heart tissue.
Dr Adam Perriman, the study’s lead author, Associate Professor in Biomaterials, UKRI Future Leaders Fellow and founder of the cell therapy technology company CytoSeek, explained: “With regenerative cell therapies, where you are trying to treat someone after a heart attack, the cells rarely go to where you want them to go. Our aim is to use this technology to re-engineer the membrane of cells, so that when they’re injected, they’ll home to specific tissues of our choice.
“We know that some bacterial cells contain properties that enable them to detect and ‘home’ to diseased tissue. For example, the oral bacterial found in our mouths can occasionally cause strep throat. If it enters the blood stream it can ‘home’ to damaged tissue in the heart causing infective endocarditis. Our aim was to replicate the homing ability of bacteria cells and apply it to stem cells.”
The team developed the technology by looking at how bacterial cells use a protein called an adhesin to ‘home’ to heart tissue. Using this theory, the researchers were able to produce an artificial cell membrane binding version of the adhesin that could be ‘painted’ on the outside of the stem cells. In an animal model, the team were able to demonstrate that this new cell modification technique worked by directing stem cells to the heart in a mouse.
Dr Perriman added: “Our findings demonstrate that the cardiac homing properties of infectious bacteria can be transferred to human stem cells. Significantly, we show in a mouse model that the designer adhesin protein spontaneously inserts into the plasma membrane of the stem cells with no cytotoxity, and then directs the modified cells to the heart after transplant. To our knowledge, this is the first time that the targeting properties of infectious bacteria have been transferred to mammalian cells.
“This new technique carries enormous potential for the seven million people currently living with heart disease in the UK.”
Learn more: Scientists hijack bacteria’s homing ability
The Latest on: Cardiovascular disease
via Google News
The Latest on: Cardiovascular disease
- Hyperventilation-induced heart rate response as a potential marker for cardiovascular diseaseon November 29, 2019 at 2:28 am
The present study suggests that a hyperventilation-induced increase in heart rate (HRR HV) is attenuated in patients with cardiovascular disease. HRR HV should be further investigated for its ...
- New and old drugs may offer new ways to fight heart diseaseon November 29, 2019 at 2:00 am
The first few of these "RNA-interference" drugs recently were approved for other conditions, and research is also targeting heart disease. Farthest along is inclisiran, tested in 1,561 people with ...
- What to know about blood thinners for heart diseaseon November 28, 2019 at 9:07 pm
Blood clots can cause different types of heart disease. People can also develop heart disease if they have atherosclerosis, which is a buildup of fatty deposits in the arteries. Blood clots can ...
- Pharmacist-led interventions may help prevent cardiovascular diseaseon November 28, 2019 at 12:18 am
A review and analysis published in the British Journal of Clinical Pharmacology indicates that initiatives—such as patient education, medication review, and physical assessments—led by pharmacists can ...
- Global Coronary Artery Disease Therapeutics Market 2019-Gilead, Novartis, Pfizeron November 27, 2019 at 9:16 pm
Nov 28, 2019 (Eon Market Research via COMTEX) -- The industry analysis on Global Coronary Artery Disease Therapeutics Market 2019 includes the complete features of the Coronary Artery Disease ...
- IDTechEx Research Reports: The Cardiovascular Disease Technology Market Will Exceed $40 Billion by 2030on November 27, 2019 at 4:02 pm
BOSTON, Nov. 27, 2019 /PRNewswire/ -- Cardiovascular disease (CVD) is currently the leading cause of death globally. The World Health Organisation reported that CVD, which encompasses all conditions ...
- Cancer patients, survivors face increased risk of heart disease deathson November 27, 2019 at 12:04 pm
Many cancer patients and survivors die from heart disease rather than from their tumors, especially if they have certain malignancies like breast and prostate cancer, a U.S. study suggests.
- Breast milk could help prevent heart disease caused by premature birthon November 27, 2019 at 8:49 am
Early use of breast milk could play a vital role in preventing heart disease in prematurely born infants, according to a paper led by researchers at RCSI (Royal College of Surgeons in Ireland) and the ...
- Global Coronary Artery Disease Therapeutics Market 2019 – Bristol-Myers Squibb, GlaxoSmithKline, Merck, Mylanon November 26, 2019 at 8:12 pm
Nov 27, 2019 (Eon Market Research via COMTEX) -- Worldwide Coronary Artery Disease Therapeutics Market 2019 Research Report presents a professional and complete analysis of Global Coronary Artery ...
- Cancer patients are at a higher risk of dying from heart disease and stroke, new study showson November 26, 2019 at 2:19 pm
Cancer patients are at higher risk of dying from heart disease and stroke than the general population, a new study finds. Certain types of cancer, including breast, prostate, endometrial and thyroid ...
via Bing News